{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T16:31:49Z","timestamp":1748449909831,"version":"3.40.5"},"reference-count":24,"publisher":"Korean College of Neuropsychopharmacology","issue":"2","license":[{"start":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T00:00:00Z","timestamp":1590883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["www.cpn.or.kr"],"crossmark-restriction":true},"short-container-title":["Clin Psychopharmacol Neurosci"],"published-print":{"date-parts":[[2020,5,31]]},"DOI":"10.9758\/cpn.2020.18.2.322","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T09:26:28Z","timestamp":1587720388000},"page":"322-326","update-policy":"https:\/\/doi.org\/10.9758\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk of Neuroleptic Malignant Syndrome with Vesicular Monoamine Transporter Inhibitors"],"prefix":"10.9758","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2840-4763","authenticated-orcid":false,"given":"Stanley N.","family":"Caroff","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Corporal Michael J. Crescenz VA Medical Center and University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4713","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750280059011"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1455504"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.6.870"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000640"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30278-4"},{"key":"ref6","unstructured":"Caroff SN. The neuroleptic malignant syndrome. J Clin Psychiatry 1980;41:79-83."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2019.17.3.450"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.31.8.1022"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.150.1.104"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199202000-00009"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870110118"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120219"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050583"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00124509-199909000-00009"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-004-0355-x"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1307082"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.53.1717"},{"key":"ref18","unstructured":"Noori MR, Boroughf WJ, Hatten BW. Back pain and muscle stiffness: a case of valbenazine-associated neuroleptic malignant syndrome. Clin Toxicol 2019;57:564-565."},{"key":"ref19","unstructured":"Illing M, Ancill R. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS. Can J Psychiatry 1996;41:258."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2016.14.3.302"},{"key":"ref21","unstructured":"Reches A, Burke RE, Kuhn CM, Hassan MN, Jackson VR, Fahn S. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain. J Pharmacol Exp Ther 1983;225:515-521."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.239160"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Huddleston DE, Factor SA. Parkinsonism-hyperpyrexia syndrome in Parkinson's disease. In: Frucht SJ editor. Movement disorder emergencies: diagnosis and treatment. New York: Humana Press;2013. p.43-57.","DOI":"10.1007\/978-1-60761-835-5_3"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2011.11.016"}],"container-title":["Clinical Psychopharmacology and Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2020\/018\/cpn018-02-17.pdf","content-type":"unspecified","content-version":"tdm","intended-application":"text-mining"},{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2020\/018\/cpn018-02-17.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T05:54:06Z","timestamp":1666418046000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2020.18.2.322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,31]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5,31]]}},"alternative-id":["10.9758\/cpn.2020.18.2.322"],"URL":"https:\/\/doi.org\/10.9758\/cpn.2020.18.2.322","relation":{},"ISSN":["1738-1088","2093-4327"],"issn-type":[{"type":"print","value":"1738-1088"},{"type":"electronic","value":"2093-4327"}],"subject":[],"published":{"date-parts":[[2020,5,31]]},"assertion":[{"value":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2020.18.2.322","URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2020.18.2.322","name":"the_journal","label":"Clinical Psychopharmacology and Neuroscience","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2019-10-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"https:\/\/orcid.org\/0000-0003-2840-4763","URL":"https:\/\/orcid.org\/0000-0003-2840-4763","name":"author","label":"Stanley N. Caroff","group":{"name":"orcid","label":"ORCID"}},{"value":"\u00a9 2020 The Korean College of Neuropsychopharmacology","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}